Stemcell Holdings, Inc. Share Price Other OTC
Equities
STMM
US85858N2027
Pharmaceuticals
Sales 2016 | 3.34M 263M | Sales 2017 | 6.18M 487M | Capitalization | 1.64M 129M |
---|---|---|---|---|---|
Net income 2016 | 1M 78.82M | Net income 2017 | 2M 158M | EV / Sales 2016 * | - |
Net cash position 2016 * | - 0 | Net cash position 2017 * | - 0 | EV / Sales 2017 * | - |
P/E ratio 2016 * |
-
| P/E ratio 2017 * |
-
| Employees | - |
Yield 2016 * |
-
| Yield 2017 * |
-
| Free-Float | 99% |
1st Jan change | Capi. | |
---|---|---|
+2.46% | 93.98B | |
-3.42% | 37.69B | |
-12.43% | 32.99B | |
+74.27% | 28.27B | |
-11.70% | 16.17B | |
+1.53% | 14.33B | |
-12.82% | 11.44B | |
+190.36% | 10.96B | |
-54.07% | 9.26B |